Shilpa Medicare demerging API business to take it public

Listed pharmaceutical firm Shilpa Medicare Ltd is demerging its active pharmaceutical ingredients (API) business into a separate company with the plan to take it public through an initial public offering (IPO) to raise upwards of ₹1,000 crore